<- Go Home

Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Market Cap

NOK 4.2B

Volume

16.9K

Cash and Equivalents

NOK 209.8M

EBITDA

NOK 201.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

NOK 581.1M

Profit Margin

80.71%

52 Week High

NOK 292.00

52 Week Low

NOK 186.50

Dividend

3.51%

Price / Book Value

8.23

Price / Earnings

26.70

Price / Tangible Book Value

10.09

Enterprise Value

NOK 4.0B

Enterprise Value / EBITDA

19.03

Operating Income

NOK 194.1M

Return on Equity

32.08%

Return on Assets

18.68

Cash and Short Term Investments

NOK 209.8M

Debt

NOK 34.6M

Equity

NOK 506.7M

Revenue

NOK 719.9M

Unlevered FCF

NOK 118.2M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches